By Gerberal | July 7, 2026 | 11 min read
"Small-cap" is one of the most useful category labels in investing — and one of the most deceptive when applied across borders. A US small-cap stock in the Russell 2000 has a median market cap of roughly $1 billion. A Chinese small-cap stock in the CSI 1000 has a median market cap of roughly ¥6 billion ($820 million). A ChiNext GEM stock might be a ¥30 billion ($4 billion) company growing at 40% annually. Same label. Completely different animals.
The academic case for small-caps is well-established: the size premium — small companies outperforming large ones over long periods — has been documented since Fama and French published their three-factor model in 1992. But the premium is not uniform across markets, not consistent across time periods, and not accessible through the same ETF vehicles. For a comprehensive overview of how factor tilts like size, value, and quality work across markets, see our factor investing and smart beta guide.
This article compares the three main small-cap ETF routes for global investors: the Russell 2000 (US), the CSI 500 (China mid-cap), and ChiNext GEM (China growth board).
Small-Cap Definitions: Three Markets, Three Meanings
| Dimension | US Small-Cap | China Mid-Cap (CSI 500) | China Growth (ChiNext GEM) |
|---|---|---|---|
| Benchmark Index | Russell 2000 | CSI 500 | ChiNext Index / GEM Index |
| Constituent Range | 1,001–3,000 by market cap | 301–800 by market cap | ~1,350 ChiNext-listed stocks |
| Median Market Cap | ~$1.0B | ||
| Listing Venue | NYSE, Nasdaq | Shanghai + Shenzhen Main Board | Shenzhen ChiNext Board |
| IPO Rules | Standard SEC registration | CSRC approval; profitability requirement | Registration-based (2020 reform); no profitability requirement |
| Foreign Access | Direct; any broker | Stock Connect (limited); QFII | Stock Connect (limited); QFII |
| Index P/E (mid-2026) | ~15x (trailing) | ~35x | ~45x |
| Dividend Yield | ~1.5% | ~1.2% | ~0.6% |
The structural differences are immediately clear:
- US small-caps are cheap but slow-growing. The Russell 2000 trades at ~15x earnings — comparable to the S&P 500 on a P/E basis — and contains many cyclical, financial, and regional bank stocks. These are real businesses, often profitable, just smaller.
- CSI 500 stocks are mid-cap by US standards. At a median ~$3 billion market cap, these would fall in the S&P MidCap 400 range. They are China's "next 500" — the companies below the CSI 300 blue chips.
- ChiNext stocks are growth-first. Modeled after the NASDAQ, ChiNext (创业板) was launched in 2009 as China's answer to a growth exchange. The 2020 registration-based IPO reform removed profitability requirements, opening the door to pre-profit biotech, SaaS, and semiconductor companies. The result: ~45x P/E, minimal dividends, maximum growth optionality.
Major ETFs Compared
US Small-Cap ETFs
| ETF | Ticker | Expense Ratio | AUM | Holdings | Strategy |
|---|---|---|---|---|---|
| iShares Russell 2000 ETF | IWM | 0.19% | ~$65B | ~1,950 stocks | Broad Russell 2000; market-cap weighted |
| Vanguard Small-Cap ETF | VB | 0.05% | ~$55B | ~1,400 stocks | CRSP US Small Cap Index; extends into lower mid-cap |
| iShares Core S&P Small-Cap ETF | IJR | 0.06% | ~$80B | ~600 stocks | S&P 600 (profitability-screened); higher quality |
| Schwab US Small-Cap ETF | SCHA | 0.04% | ~$18B | ~1,700 stocks | Dow Jones US Small-Cap; lowest cost |
| Avantis US Small Cap Value ETF | AVUV | 0.25% | ~$15B | ~700 stocks | Active rules-based; value + profitability tilt |
Key distinction: IJR (S&P 600) requires constituents to have positive trailing earnings — a quality screen the Russell 2000 lacks. As a result, IJR has historically outperformed IWM with lower volatility. Since inception, IJR's annualized return exceeds IWM's by ~1.5% with a lower drawdown profile. The quality filter matters in small-caps. For investors who want to complement small-cap exposure with mid-cap positions, our mid-cap ETF guide covers the S&P 400 and similar strategies.
IWM Top Sector Exposure (mid-2026)
| Sector | Weight | Commentary |
|---|---|---|
| Financials | ~18% | Regional banks, insurance, REITs — rate-sensitive |
| Industrials | ~16% | Manufacturers, construction, logistics |
| Healthcare | ~14% | Biotech (many unprofitable), medical devices |
| Technology | ~13% | Software, IT services, semiconductors |
| Consumer Discretionary | ~11% | Retail, restaurants, leisure |
| Real Estate | ~7% | Small-cap REITs |
China Mid/Small-Cap ETFs
| ETF | Ticker | Expense Ratio | AUM | Market | Strategy |
|---|---|---|---|---|---|
| Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF | ASHS | 0.65% | ~$35M | US-listed | Physical replication of CSI 500 |
| CSOP CSI 500 ETF (A-share) | 510500 | 0.50% | ~¥6B | Onshore | CSI 500; highest liquidity |
| ChinaAMC CSI 500 ETF (A-share) | 512500 | 0.50% | ~¥3B | Onshore | CSI 500 |
| ChinaAMC ChiNext ETF (A-share) | 159915 | 0.50% | ~¥18B | Onshore | ChiNext Index; most liquid GEM ETF |
| E Fund ChiNext ETF (A-share) | 159915 | 0.50% | ~¥10B | Onshore | ChiNext Index |
For US-based investors, ASHS is the primary liquid option for CSI 500 exposure, though it's small ($35M AUM) and relatively expensive at 0.65%. There is no US-listed ChiNext-only ETF; investors wanting pure ChiNext exposure must use A-share accounts, Stock Connect, or Hong Kong-listed ChiNext ETF feeders.
CSI 500 vs ChiNext: Sector Divergence
| Sector | CSI 500 Weight | ChiNext GEM Weight |
|---|---|---|
| Technology | ~25% | ~35% |
| Healthcare | ~12% | ~20% |
| Industrials | ~18% | ~12% |
| Financials | ~10% | ~3% |
| Consumer | ~15% | ~10% |
| Materials | ~12% | ~8% |
| New Energy / EV | ~5% | ~12% |
ChiNext is much heavier in technology, healthcare, and new energy — the "new economy" sectors China is actively promoting. CSI 500 is more balanced, with meaningful exposure to industrials, materials, and financials.
Performance: Size Premium vs Growth Premium
| Period | IWM (Russell 2000) | ASHS (CSI 500) | 159915 (ChiNext) |
|---|---|---|---|
| YTD 2026 | +3.2% | +5.8% | +8.5% |
| 2025 | +10.5% | +8.2% | +15.3% |
| 2024 | +11.2% | −6.1% | −12.8% |
| 2023 | +15.1% | −10.4% | −18.5% |
| 5-Year Ann. (2021–2025) | +7.8% | +2.1% | +6.8% |
| 10-Year Ann. (2016–2025) | +8.2% | +3.8% | +7.5% |
The data tells three different stories:
Russell 2000 (IWM): Steady, compounding returns over 10 years — but underperformed the S&P 500 over the same period (+13.5% annualized for SPY vs +8.2% for IWM). The US size premium has been negative for over a decade, largely because mega-cap tech (Apple, Microsoft, Nvidia) captured disproportionate earnings growth.
CSI 500 (ASHS): High volatility, disappointing long-term returns. The CSI 500 has been a weak performer, dragged down by China's economic slowdown, property sector spillovers, and a market that has favored either mega-cap SOEs (CSI 300) or speculative growth (ChiNext) while neglecting the middle.
ChiNext (159915): The best 10-year return of the three, but with gut-wrenching drawdowns. ChiNext fell ~35% in 2022, ~18% in 2023, and ~13% in 2024 before rebounding in 2025-2026. Owning ChiNext requires tolerance for 30-50% drawdowns every few years.
Structural Differences That Drive Returns
1. Profitability Filter
The S&P 600 (IJR) requires constituents to have positive trailing GAAP earnings. The Russell 2000 (IWM) does not — roughly 30-40% of Russell 2000 companies are unprofitable in any given year. The CSI 500 constituents are mostly profitable (main board listing requires it), while ChiNext includes many pre-profit companies.
Implication: An IJR-style approach (profitability-screened) is not available for China small-caps through passive ETFs. Active selection matters more in China.
2. Sector Composition
The Russell 2000 is heavy in financials and industrials — cyclical, value-oriented sectors. The CSI 500 is more balanced across old and new economy. ChiNext is a growth board — tech, biotech, new energy dominate.
Implication: US small-cap exposure is partly a cyclical/value bet. China small-cap exposure (especially ChiNext) is a growth/innovation bet. They serve different portfolio roles. For a comparison of how growth and value styles perform across market caps, our growth vs value ETF guide provides a framework for understanding style tilts.
3. IPO Dynamics
The Russell 2000 gains new constituents as companies grow into it and IPOs list. Turnover is moderate (~5-8% annually). ChiNext sees high IPO volume and high turnover — successful companies graduate to the main board or CSI 300, leaving ChiNext constantly replenished with new, young companies.
Implication: ChiNext's index composition is inherently younger and riskier than the Russell 2000. The long-term return includes a survivorship bias — companies that fail are removed, and new IPOs replace them.
4. Policy Sensitivity
| Factor | Russell 2000 | CSI 500 | ChiNext |
|---|---|---|---|
| Interest rate sensitivity | High (regional banks, REITs) | Moderate | Low |
| Trade/tariff sensitivity | Low (mostly domestic) | Moderate | High (tech supply chain) |
| Domestic policy sensitivity | Low | High (CSRC, economic policy) | Very high (tech policy, IPO rules) |
| Currency sensitivity | None (USD-denominated) | Moderate (RMB) | Moderate (RMB) |
Portfolio Integration: How Much, and Which One?
Case for Russell 2000 (IWM/IJR)
- Measured size premium: If you believe US mega-caps are overvalued and mean-reversion favors smaller companies, IWM is the vehicle. The valuation gap between large and small caps is at historic extremes.
- Quality tilt available: IJR (S&P 600) provides small-cap exposure with a profitability screen. AVUV adds a value tilt. You don't have to buy the entire unprofitable tail of the Russell 2000.
- Liquidity and low cost: IWM trades with penny-wide spreads; expense ratios are as low as 0.04% (SCHA).
- Domestic diversification: Adding small-caps reduces concentration in the 5-7 mega-cap tech names that dominate the S&P 500.
Case for CSI 500 (ASHS)
- China mid-cap value play: CSI 500 is overlooked — it's not as prestigious as CSI 300 and not as exciting as ChiNext. That neglect can create opportunity.
- Broader China exposure: If you only own CSI 300 ETFs, you're concentrated in mega-cap banks, SOEs, and the largest tech names. CSI 500 adds manufacturing, regional leaders, and second-tier growth companies.
- Lower correlation with US equities: China A-shares generally have ~0.4-0.5 correlation with US equities. Small/mid-cap A-shares have even lower correlation. For investors exploring China A-share sector exposures beyond market-cap indices, our A-share industry ETF guide covers sector-specific Chinese ETFs.
Case for ChiNext (159915)
- Pure growth exposure: If you want to bet on China's innovation economy — biotech, semiconductors, EVs, AI applications — ChiNext is the most concentrated expression.
- IPO and new economy access: Many of China's most innovative companies list on ChiNext first (or STAR Market, which is similar). The growth board captures earlier-stage innovation than the main board.
- Policy alignment: ChiNext aligns with China's stated goal of becoming self-sufficient in technology. Policy support (R&D subsidies, tax incentives, IPO fast-tracks) disproportionately benefits ChiNext-listed companies. For context on how ChiNext compares to the CSI 300 blue chips and CSI 1000 for small-cap, our CSI 500 vs CSI 1000 comparison provides a comprehensive breakdown of China's market-cap spectrum.
Allocation Framework
| Investor Profile | US Small-Cap | CSI 500 | ChiNext | Rationale |
|---|---|---|---|---|
| US total-market investor | 5-10% (IJR or VB) | 0-2% | 0% | Small-cap completion for S&P 500; optional China satellite |
| Global balanced | 5-8% | 2-4% | 0-2% | US small-cap core; China mid-cap for diversification; ChiNext as tactical |
| China specialist | 0-5% | 5-10% | 5-10% | Core China exposure across market cap spectrum |
| Aggressive growth | 5-10% (AVUV) | 2-5% | 5-15% | Factor tilt (US value) + China growth optionality |
The Bottom Line
"Small-cap" means fundamentally different things in the US and China. The Russell 2000 is a mature, deep, liquid market of mostly-profitable smaller companies — cheap on P/E, cyclical in composition, and a useful diversifier against mega-cap concentration. CSI 500 is China's overlooked middle child — mid-cap companies that are larger than US small-caps but face a more challenging macro environment. ChiNext GEM is China's NASDAQ — high-growth, high-volatility, high-P/E, and the best pure-play on China's innovation economy, but only for investors who can stomach 30-50% drawdowns.
The three don't compete. A reasonable portfolio might hold IJR (quality-screened US small-caps) for steady factor exposure, a small CSI 500 position for China mid-cap diversification, and ChiNext as a tactical growth satellite. The key is knowing which bet you're making with each — size, quality, growth, or policy — and sizing accordingly.
Continue reading: For mid-cap exposure that bridges the gap between large and small, see our mid-cap ETFs guide. If you're interested in how equal-weighting strategies can reduce concentration risk in any market-cap segment, our equal-weight vs cap-weight ETF comparison covers the trade-offs.
Sources
- Fama, E.F. & French, K.R. (1992) — "The Cross-Section of Expected Stock Returns," Journal of Finance (three-factor model introducing the size premium)
- FTSE Russell — Russell 2000 Index methodology, constituent data, and annual reconstitution rules
- S&P Dow Jones Indices — S&P 600 Index methodology (profitability screen requirement) and performance data
- China Securities Index Co. (中证指数) — CSI 500 Index methodology and constituent list, 2026
- Shenzhen Stock Exchange — ChiNext Board listing rules, IPO reform documentation (2020 registration-based system)
- iShares (BlackRock) — IWM, IJR fund documentation and sector exposure data
- Xtrackers / DWS — ASHS (CSI 500 China A-Shares Small Cap) fund prospectus
- Morningstar — US small-cap vs large-cap historical return premium analysis and rolling period data
Disclaimer: ETF Bridge is an educational resource. This article does not constitute investment advice. Past performance does not guarantee future results. Small-cap and emerging-market ETFs carry elevated volatility and liquidity risk. ChiNext GEM stocks are subject to higher regulatory uncertainty, delisting risks, and currency exposure. Always conduct your own due diligence before investing.